BeStock  
Markets › Compare › ZYME vs VERA

ZYME vs VERA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ZYME · Zymeworks$26.14 ▼ 2.68%
VERA · Vera Therapeutics$25.45 ▼ 4.86%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

81110139168197Nov 24, '25May 26, '26Nov 20, '26
  • ZYME +4.6%
  • VERA -13.0%

Head to head

MetricZYMEVERA
Price$26.14$25.45
Change today▼ 2.68%▼ 4.86%
Market cap$1.81B$1.84B
Return, 3 months-9.1%-24.5%
Return, year to date-0.7%-49.7%
Return, 1 year+8.8%-10.6%
P/E (TTM)49.3–
P/B7.05.5
P/E percentile vs own 5y100th78th
Dividend yield––
Revenue growth (YoY, latest qtr)+828.7%–
Net profit growth (YoY)+986.1%-16.7%
Gross margin–67.9%
Operating margin16.6%-4,160.1%
Net margin16.3%-4,041.2%
Return on equity15.0%-113.5%
Analyst target vs. price+60.0%+175.8%
Analyst buy share100%83%
RSI (14)4336
30-day volatility56.5%62.4%
Max drawdown, 1 year-23.6%-54.3%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VERA is the largest of the group by market value.
  • ZYME has returned the most over the past year.
  • ZYME keeps the most profit per dollar of sales.
  • ZYME has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top